Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Puerta de Hierro (7)

2022

  1. Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis

    Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 4, pp. 614-624

2016

  1. Toward liquid biopsy: Determination of the humoral immune response in cancer patients using halotag fusion protein-modified electrochemical bioplatforms

    Analytical Chemistry, Vol. 88, Núm. 24, pp. 12339-12345

2015

  1. LOXL2 is highly expressed in cancer-associated fibroblasts and associates to poor colon cancer survival

    Clinical Cancer Research, Vol. 21, Núm. 21, pp. 4892-4902

2014

  1. Snail1 Expression Is Required for Sarcomagenesis

    Neoplasia (United States), Vol. 16, Núm. 5, pp. 413-421

2013

  1. Evaluation of a minimally aggressive method of patellofemoral osteoarthritis treatment at 10 years minimum follow-up

    Knee, Vol. 20, Núm. 6, pp. 476-481

  2. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer

    Clinical Cancer Research, Vol. 19, Núm. 21, pp. 6006-6019

2010

  1. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

    Annals of Hematology, Vol. 89, Núm. 11, pp. 1073-1080